Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29; p. viii373
Main Authors: Ho, A.L., Chau, N., Bauman, J., Bible, K., Chintakuntlawar, A., Cabanillas, M.E., Wong, D.J., Braña Garcia, I., Brose, M.S., Boni, V., Even, C., Razaq, M., Mishra, V., Bracken, K., Wages, D., Scholz, C., Gualberto, A.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-10-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy287.002